logo

For the Inventor, By the Inventor

Versoix, Sweden

Symphar S.a.

Calculating rank
USPTO Granted Patents = 12

Forward Citations = 107

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Craig Leigh Bentzen (10 out of 15 patents)

silverMedal Eric Joseph Niesor (9 out of 19 patents)

bronzeMedal Hieu Trung Phan (6 out of 11 patents)

4.  Lan Mong Nguyen (5 out of 9 patents)

5.  Yves Guyon-Gellin (3 out of 4 patents)

6.  Lan Nguyen Mong (3 out of 3 patents)

7.  Pierre Maechler (2 out of 2 patents)

8.  Lan N Mong (2 out of 2 patents)

9.  Lawrence I Kruse (1 out of 45 patents)

10.  Robert John Ife (1 out of 63 patents)

11.  Raymond Azoulay (1 out of 6 patents)

12.  Vinh Van Diep (1 out of 6 patents)

13.  Alexandre Bulla (1 out of 2 patents)

14.  Simon Floret (1 out of 3 patents)

15.  Jean-Luc Thuillard (1 out of 1 patent)


12 patents:

1. 6127350 - Use of phenol substituted diphosphonates as antineoplastic agents (2000-10-03),
2. 6060464 - Compounds and pharmaceutical compositions containing them (2000-05-09),
3. 5424303 - Substituted aminophosphonate derivatives, process for their preparation (1995-06-13),
4. 5204336 - Naphthyl-,tetrahydronaphthyl-, and indanyl-substituted (1993-04-20),
5. 5128331 - Method for lowering plasma lipid levels or blood pressure (1992-07-07),
6. 5043330 - Phenol substituted gem-diphosphonate derivatives, process for their (1991-08-27),
7. 4696920 - Certain 2-substituted 1,3-propylidenediphosphonate derivatives, (1987-09-29),
8. 4416877 - Anti-atherosclerotic pharmaceutical compositions containing (1983-11-22),
9. 4371527 - Therapeutic process with diphosphonate compounds (1983-02-01),
10. 4309364 - Diphosphonates (1982-01-05),
11. 4309188 - Method for the clinical separation of .alpha.- and .beta.-lipoproteins (1982-01-05),
12. 4268507 - Monophosphonate compounds as hypoglycemic and/or antiartherogenic agents (1981-05-19),
Company Overview
Symphar S.a. is a prominent player in the pharmaceutical industry, specializing in the development and manufacturing of high-quality generic and specialty medications. The company is committed to advancing healthcare solutions through innovative drug formulations and delivery systems. With a focus on research and development, Symphar operates within various therapeutic areas, aiming to enhance patient outcomes. Based in Versoix, Switzerland, the organization leverages its expertise to serve both local and international markets.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

12 Patents

#1 in Versoix

#928 in Sweden

#48,235 in the World

Versoix, SE
Versoix, Sweden

Symphar S.a.

Forward Citations = 107

19 inventors:

goldMedal Craig Leigh Bentzen (10 out of 15 patents)

silverMedal Eric Joseph Niesor (9 out of 19 patents)

bronzeMedal Hieu Trung Phan (6 out of 11 patents)

4.  Lan Mong Nguyen (5 out of 9 patents)

5.  Yves Guyon-Gellin (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Symphar S.a.. Retrieved from https://idiyas.com/company/symphar-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…